Although TNBC have showed an extreme sensitivity to THZ1 compared to HR+ breast cancer, different responses to the CDK7 inhibitor still exist among different TNBC cell lines shown by us and Wang and coworkers3. Here, CDK7 is linked to breast carcinoma.